The number of diabetics is expected to reach 330 million in 2025, while it was 194 million in 2003. The prevalence of diabetes will increase all around the world. As 60% of total treated patients are still not adequately controlled, there is a pressing need for better treatments. To meet the growing expectations, innovation should provide solutions to improve prevention and treatment as well as to address all stages of the disease. Alliances between big pharma and biotech companies and between public and private research organisations are key to provide innovative options to
improve diabetes management.

• Show why diabetes is a Public Health priority
• Explain the strategy and ambition in terms of research for answering the medical needs
• Show the need for partnering to benefit from the impressive business acceleration in diabetes